Profile | GDS4284 / 229028_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1012.22 | 74 |
GSM687648 | Patient 402 control | 2604.52 | 87 |
GSM687653 | Patient 403 control | 2343.93 | 86 |
GSM687658 | Patient 404 control | 2266.08 | 85 |
GSM687663 | Patient 411 control | 1138.74 | 76 |
GSM687668 | Patient 422 control | 818.16 | 71 |
GSM687673 | Patient 424 control | 571.032 | 65 |
GSM687678 | Patient 425 control | 1894.56 | 83 |
GSM687683 | Patient 427 control | 1307.45 | 78 |
GSM687688 | Patient 428 control | 684.542 | 68 |
GSM687695 | Patient 441 control | 1668.89 | 83 |
GSM687699 | Patient 443 control | 1203.97 | 77 |
GSM687704 | Patient 444 control | 1011.65 | 74 |
GSM687707 | Patient 448 control | 1502.86 | 80 |
GSM687712 | Patient 449 control | 1846.18 | 83 |
GSM687719 | Patient 450 control | 1437.35 | 79 |
GSM687724 | Patient 451 control | 1378.32 | 79 |
GSM687728 | Patient 452 control | 1761.45 | 83 |
GSM687646 | Patient 401 treated 24h | 867 | 71 |
GSM687649 | Patient 402 treated 24h | 3012.52 | 89 |
GSM687665 | Patient 411 treated 24h | 1070.09 | 75 |
GSM687651 | Patient 402 treated 4 weeks | 2338.76 | 86 |
GSM687667 | Patient 411 treated 4 weeks | 1502.75 | 80 |
GSM687670 | Patient 422 treated 24h | 696.433 | 68 |
GSM687671 | Patient 422 treated 4 weeks | 972.044 | 73 |
GSM687654 | Patient 403 treated 24h | 2102.85 | 85 |
GSM687675 | Patient 424 treated 24h | 435.735 | 61 |
GSM687685 | Patient 427 treated 24h | 1478.96 | 80 |
GSM687656 | Patient 403 treated 4 weeks | 2177.13 | 85 |
GSM687677 | Patient 424 treated 4 weeks | 498.976 | 63 |
GSM687687 | Patient 427 treated 4 weeks | 1553.12 | 80 |
GSM687692 | Patient 428 treated 4h | 733.515 | 69 |
GSM687716 | Patient 449 treated 4h | 1783.43 | 82 |
GSM687722 | Patient 450 treated 4h | 1563.7 | 81 |
GSM687680 | Patient 425 treated 24h | 2267.28 | 85 |
GSM687690 | Patient 428 treated 24h | 863.073 | 72 |
GSM687700 | Patient 443 treated 24h | 1482.64 | 80 |
GSM687705 | Patient 444 treated 24h | 1271.27 | 78 |
GSM687714 | Patient 449 treated 24h | 2191.35 | 85 |
GSM687721 | Patient 450 treated 24h | 1344.2 | 79 |
GSM687682 | Patient 425 treated 4 weeks | 1580.21 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 884.508 | 72 |
GSM687702 | Patient 443 treated 4 weeks | 1203.8 | 76 |
GSM687718 | Patient 449 treated 4 weeks | 1542.8 | 81 |
GSM687723 | Patient 450 treated 4 weeks | 1624.37 | 81 |
GSM687661 | Patient 404 treated 4h | 2209.44 | 85 |
GSM687710 | Patient 448 treated 4h | 1213.36 | 77 |
GSM687726 | Patient 451 treated 4h | 1365 | 79 |
GSM687730 | Patient 452 treated 4h | 1644.82 | 83 |
GSM687660 | Patient 404 treated 24h | 1498.78 | 82 |
GSM687697 | Patient 441 treated 24h | 1506.39 | 81 |
GSM687709 | Patient 448 treated 24h | 1152.16 | 76 |
GSM687725 | Patient 451 treated 24h | 1140.64 | 76 |
GSM687729 | Patient 452 treated 24h | 1096.69 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 1263.9 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 1520.91 | 80 |